A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy
Status:
Terminated
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
This study was designed to demonstrate that AQUAVAN® is effective in providing adequate
sedation in elderly patients undergoing colonoscopy as well as to assess the safety profile
of AQUAVAN versus that of midazolam. Prior to the procedure, patients received fentanyl
citrate for pain management followed five minutes later by AQUAVAN® Injection for sedation.
Throughout the procedure, study personnel assessed the patient's vital signs and depth of
sedation. After the procedure, the patient, physician, and an evaluator were asked to
complete satisfaction surveys.